Guidant Cites Ethics In Countering Drug-Eluting Stent Data Enjoinment
This article was originally published in The Gray Sheet
Executive Summary
Guidant is relying on two ethical arguments to persuade a federal judge not to block access to clinical drug-eluting stent data collected in collaboration with Cook, Inc
You may also be interested in...
Guidant’s $3 Bil. Cook Purchase Hinges On Ownership Of Subsidiary, Data
Guidant's $3 bil. purchase of Cook Group does not represent a "change of ownership" under the terms of a 1997 licensing agreement between subsidiary Cook, Inc., Angiotech Pharmaceuticals and Boston Scientific, Guidant asserts
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.